Scinai Immunotherapeutics Ltd. - SCNI - Fundamentals

Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Insider Tracker is here!

Try it now Watch the presentation

‌
‌

‌

Let's get started...

‌

Breakdown

2008

12/31

2009

12/31

2010

12/31

2011

12/31

2012

12/31

2013

12/31

2014

12/31

2015

12/31

2016

12/31

2017

12/31

2018

12/31

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

+99.24%

+13.93%

📊

Revenue Growth (5Y)

📊

Revenue Growth (10Y)

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

-8.79%

+13.83%

+120.38%

-100.00%

-25.13%

-8.42%

+141.48%

+220.11%

+32.83%

📊

Cost of Revenue Growth (5Y)

-100.00%

+430.06%

+604.08%

📊

Cost of Revenue Growth (10Y)

-100.00%

📊

Gross Profit

-0

-1

-3

-4

📊

Gross Profit Growth (1Y)

+8.79%

-13.83%

-120.38%

+100.00%

+25.13%

+8.42%

-13.13%

-357.24%

-42.17%

📊

Gross Profit Growth (5Y)

+100.00%

-254.71%

-404.31%

📊

Gross Profit Growth (10Y)

+100.00%

📊

Operating Expenses

-2

📊

Operating Expenses Growth (1Y)

-9.83%

+123.11%

-13.43%

+2.42%

+0.80%

-5.17%

+38.82%

+6.48%

+120.11%

+203.13%

+10.09%

-110.06%

+576.02%

+1.83%

-12.25%

-16.98%

-39.31%

-15.93%

📊

Operating Expenses Growth (5Y)

+78.39%

+99.41%

-15.24%

+35.91%

+41.28%

+208.53%

+886.20%

+682.15%

-173.88%

+59.77%

-46.33%

-57.22%

+453.14%

-54.98%

-62.15%

📊

Operating Expenses Growth (10Y)

+454.77%

+1764.99%

+820.27%

-206.91%

+396.86%

+401.96%

+364.47%

+177.78%

+58.32%

+33.11%

📊

Sell General Administrative

📊

Research and Development

📊

Other Income Expenses

-0

-1

-0

-23

-0

📊

EBITDA

-1

-2

-3

-7

-21

-22

-10

-9

-7

-8

📊

EBITDA Growth (1Y)

+3.44%

-119.62%

+17.40%

-12.31%

+10.65%

+4.16%

-42.99%

-6.86%

-127.91%

-207.83%

-8.15%

+112.38%

-477.80%

-1.04%

+12.45%

+23.97%

+6.61%

-18.77%

📊

EBITDA Growth (5Y)

-96.74%

-82.04%

+20.56%

-37.52%

-30.84%

-233.76%

-972.01%

-710.78%

+193.95%

-55.74%

+48.88%

+58.62%

-354.11%

+37.19%

+25.40%

📊

EBITDA Growth (10Y)

-486.68%

-1770.34%

-821.00%

+238.06%

-364.43%

-425.19%

-379.77%

-155.11%

-122.96%

-164.80%

📊

Depreciation and Amortization

📊

Operating Income

-1

-3

-2

-3

-7

-21

-23

-11

-10

-9

-8

📊

Operating Income Growth (1Y)

+9.77%

-116.87%

+9.41%

-3.21%

+7.27%

+5.17%

-38.82%

-6.48%

-120.11%

-203.13%

-10.09%

+110.06%

-576.55%

-1.72%

+12.25%

+11.00%

+12.69%

-11.67%

📊

Operating Income Growth (5Y)

-82.95%

-88.02%

+17.78%

-25.99%

-29.98%

-208.53%

-886.20%

-682.15%

+173.88%

-59.95%

+46.33%

+57.22%

-478.56%

+30.64%

+22.55%

📊

Operating Income Growth (10Y)

-423.41%

-1658.43%

-792.68%

+199.11%

-357.60%

-401.96%

-364.47%

-197.78%

-144.18%

-172.68%

📊

Interest Expense

-0

📊

Pre Tax Income

-1

-2

-3

-2

-10

-23

-32

-1

-8

-6

-8

-3

📊

Tax Provision

📊

NET INCOME

-1

-2

-3

-2

-10

-23

-32

-1

-8

-6

-8

-3

📊

Net Income Growth (1Y)

+3.76%

-113.54%

+13.18%

-12.38%

+4.54%

+14.02%

-31.36%

+8.93%

-316.56%

-136.25%

-34.79%

+95.62%

-492.03%

+29.37%

-12.15%

+173.78%

-273.21%

+61.95%

📊

Net Income Growth (5Y)

-100.51%

-98.91%

+19.91%

-21.17%

+1.81%

-328.47%

-1077.27%

-1108.04%

+41.85%

+17.36%

+75.29%

+79.44%

+446.01%

-1.23%

+61.48%

📊

Net Income Growth (10Y)

-720.18%

-1913.47%

-1170.92%

+35.83%

-238.04%

-150.10%

-226.20%

+283.23%

-248.49%

-32.61%

📊

Basic EPS

-189.82

-173.14

-279.13

-223.97

-230.45

-193.35

-146.8

-99.22

-70.58

-197.58

-358.95

-387.21

-12.51

-87.6

-30.8

-16.8

-15,116.4

📊

Diluted EPS

-189.82

-279.13

-223.97

-230.45

-193.33

-146.8

-99.22

-70.58

-197.58

-358.95

-387.21

-12.51

-80

-30.8

-16.8

-15,116.4

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Breakdown

2008

12/31

2009

12/31

2010

12/31

2011

12/31

2012

12/31

2013

12/31

2014

12/31

2015

12/31

2016

12/31

2017

12/31

2018

12/31

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

+99.24%

+13.93%

📊

Revenue Growth (5Y)

📊

Revenue Growth (10Y)

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

-8.79%

+13.83%

+120.38%

-100.00%

-25.13%

-8.42%

+141.48%

+220.11%

+32.83%

📊

Cost of Revenue Growth (5Y)

-100.00%

+430.06%

+604.08%

📊

Cost of Revenue Growth (10Y)

-100.00%

📊

Gross Profit

-0

-1

-3

-4

📊

Gross Profit Growth (1Y)

+8.79%

-13.83%

-120.38%

+100.00%

+25.13%

+8.42%

-13.13%

-357.24%

-42.17%

📊

Gross Profit Growth (5Y)

+100.00%

-254.71%

-404.31%

📊

Gross Profit Growth (10Y)

+100.00%

📊

Operating Expenses

-2

📊

Operating Expenses Growth (1Y)

-9.83%

+123.11%

-13.43%

+2.42%

+0.80%

-5.17%

+38.82%

+6.48%

+120.11%

+203.13%

+10.09%

-110.06%

+576.02%

+1.83%

-12.25%

-16.98%

-39.31%

-15.93%

📊

Operating Expenses Growth (5Y)

+78.39%

+99.41%

-15.24%

+35.91%

+41.28%

+208.53%

+886.20%

+682.15%

-173.88%

+59.77%

-46.33%

-57.22%

+453.14%

-54.98%

-62.15%

📊

Operating Expenses Growth (10Y)

+454.77%

+1764.99%

+820.27%

-206.91%

+396.86%

+401.96%

+364.47%

+177.78%

+58.32%

+33.11%

📊

Sell General Administrative

📊

Research and Development

📊

Other Income Expenses

-0

-1

-0

-23

-0

📊

EBITDA

-1

-2

-3

-7

-21

-22

-10

-9

-7

-8

📊

EBITDA Growth (1Y)

+3.44%

-119.62%

+17.40%

-12.31%

+10.65%

+4.16%

-42.99%

-6.86%

-127.91%

-207.83%

-8.15%

+112.38%

-477.80%

-1.04%

+12.45%

+23.97%

+6.61%

-18.77%

📊

EBITDA Growth (5Y)

-96.74%

-82.04%

+20.56%

-37.52%

-30.84%

-233.76%

-972.01%

-710.78%

+193.95%

-55.74%

+48.88%

+58.62%

-354.11%

+37.19%

+25.40%

📊

EBITDA Growth (10Y)

-486.68%

-1770.34%

-821.00%

+238.06%

-364.43%

-425.19%

-379.77%

-155.11%

-122.96%

-164.80%

📊

Depreciation and Amortization

📊

Operating Income

-1

-3

-2

-3

-7

-21

-23

-11

-10

-9

-8

📊

Operating Income Growth (1Y)

+9.77%

-116.87%

+9.41%

-3.21%

+7.27%

+5.17%

-38.82%

-6.48%

-120.11%

-203.13%

-10.09%

+110.06%

-576.55%

-1.72%

+12.25%

+11.00%

+12.69%

-11.67%

📊

Operating Income Growth (5Y)

-82.95%

-88.02%

+17.78%

-25.99%

-29.98%

-208.53%

-886.20%

-682.15%

+173.88%

-59.95%

+46.33%

+57.22%

-478.56%

+30.64%

+22.55%

📊

Operating Income Growth (10Y)

-423.41%

-1658.43%

-792.68%

+199.11%

-357.60%

-401.96%

-364.47%

-197.78%

-144.18%

-172.68%

📊

Interest Expense

-0

📊

Pre Tax Income

-1

-2

-3

-2

-10

-23

-32

-1

-8

-6

-8

-3

📊

Tax Provision

📊

NET INCOME

-1

-2

-3

-2

-10

-23

-32

-1

-8

-6

-8

-3

📊

Net Income Growth (1Y)

+3.76%

-113.54%

+13.18%

-12.38%

+4.54%

+14.02%

-31.36%

+8.93%

-316.56%

-136.25%

-34.79%

+95.62%

-492.03%

+29.37%

-12.15%

+173.78%

-273.21%

+61.95%

📊

Net Income Growth (5Y)

-100.51%

-98.91%

+19.91%

-21.17%

+1.81%

-328.47%

-1077.27%

-1108.04%

+41.85%

+17.36%

+75.29%

+79.44%

+446.01%

-1.23%

+61.48%

📊

Net Income Growth (10Y)

-720.18%

-1913.47%

-1170.92%

+35.83%

-238.04%

-150.10%

-226.20%

+283.23%

-248.49%

-32.61%

📊

Basic EPS

-189.82

-173.14

-279.13

-223.97

-230.45

-193.35

-146.8

-99.22

-70.58

-197.58

-358.95

-387.21

-12.51

-87.6

-30.8

-16.8

-15,116.4

📊

Diluted EPS

-189.82

-279.13

-223.97

-230.45

-193.33

-146.8

-99.22

-70.58

-197.58

-358.95

-387.21

-12.51

-80

-30.8

-16.8

-15,116.4

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	-8.5%
Next Earnings
Market cap	0 (USD)
EPS (TTM)	-15116.40 ($)
P/E (TTM)	-0.00 ($)
Last Close	1.56

Next Earnings
Market cap	0 (USD)
EPS (TTM)	-15116.40 ($)
P/E (TTM)	-0.00 ($)
Last Close	1.56 ($)

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	-8.5%
Next Earnings
Market cap	0 (USD)
EPS (TTM)	-15116.40 ($)
P/E (TTM)	-0.00 ($)
Last Close	1.56

Next Earnings
Market cap	0 (USD)
EPS (TTM)	-15116.40 ($)
P/E (TTM)	-0.00 ($)
Last Close	1.56 ($)